Clinical Trials

90 enrolled

Breast Neoplasms

NCT07533526 2026-04-16

Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study

40 enrolled

Breast Neoplasms, Pain

NCT07504770 2026-04-15

Surgical Glove

84 enrolled

Breast Neoplasms

NCT07532096 2026-04-15

Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer

240 enrolled

Breast Neoplasms

NCT07225309 2026-04-14

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

BreastGastrointestinalGenitourinaryHead & Neck

300 enrolled

Breast Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT07527468 2026-04-14

HISMAR

228 enrolled

Margins of Excision, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular

NCT07527689 2026-04-14

HARVEST-PRO

1,950 enrolled

Breast Neoplasms

NCT07527806 2026-04-14

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

156 enrolled

Breast Neoplasms

NCT07527819 2026-04-14

FERTILE

75 enrolled

BreastGynecologic

Inflammation, Primary Ovarian Insufficiency, Triple Negative Breast Neoplasms

NCT07528638 2026-04-14

Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)

6 enrolled

Breast Neoplasms

NCT07528716 2026-04-14

Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy

280 enrolled

Breast Neoplasms

NCT07528768 2026-04-14

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

750 enrolled

Triple Negative Breast Neoplasms

NCT07528898 2026-04-14

Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.

100 enrolled

Breast Neoplasms

NCT07529353 2026-04-14

EXCAP-hEAT

20 enrolled

Breast Neoplasms

NCT07529496 2026-04-14

The Effect of Psychosocial Support on Improving Breast Cancer Patients Response to Medical Treatment

160 enrolled

Phase 1/2 Not yet recruiting

Breast Cancer - Female

NCT02802423 2026-04-13

Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

44 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06982222 2026-04-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

BreastGenitourinaryThoracic

24 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07297667 2026-04-13

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT07391774 2026-04-13

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

1,978 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT07516626 2026-04-13

BC-PDO

40 enrolled

Breast Neoplasms

NCT07522593 2026-04-13

Baduanjin Exercise on Upper Limb Dysfunction Among Breast Cancer Survivors

76 enrolled

Breast Cancer Survivor

NCT07523516 2026-04-13

Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer

97 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07523607 2026-04-13

FAP PET/CT for Staging Patients With Breast Cancer

65 enrolled

Breast Neoplasms

NCT07523789 2026-04-13

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

201 enrolled

Triple Negative Breast Neoplasms

NCT07524322 2026-04-13

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Phase 2/3 Not yet recruiting

63 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07413939 2026-04-09

BREnnA

650 enrolled

HER2-positive Breast Cancer

NCT07513311 2026-04-09

RESTORE

75 enrolled

Triple Negative Breast Neoplasms

NCT07519200 2026-04-09

SHARE-MC

96 enrolled

Breast Neoplasms

NCT07521202 2026-04-09

IMPACT PT

257 enrolled

HR+/HER2- Early Breast Cancer

NCT06658912 2026-04-08

Planning Grant for TOPS for Breast Cancer Survivors

25 enrolled

Breast Neoplasms, Weight Loss

NCT07408856 2026-04-08

CAN1012 in Pre-Malignant DCIS and LCIS

24 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT07517224 2026-04-08

Assessing the Effect of an Aerobic Exercise Program on Vascular Function in Women With Non-Metastatic Breast Cancer

40 enrolled

Breast Cancer Survivors

NCT07518173 2026-04-08

A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast Cancer

596 enrolled

HER2-positive Breast Cancer

NCT05379153 2026-04-07

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

250 enrolled

Breast Carcinoma In Situ

NCT07490938 2026-04-06

EASE

200 enrolled

Breast Cancer Survivors

NCT07497256 2026-04-06

BCT Aid

160 enrolled

Breast Neoplasms

NCT07512271 2026-04-06

Generative AI Patient Education Module for Breast Oncology

35 enrolled

Breast Neoplasms

NCT07509515 2026-04-03

QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC.

60 enrolled

Triple Negative Breast Neoplasms

NCT06882499 2026-04-02

AVATARII

74 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07340658 2026-04-02

SIE-3

300 enrolled

Breast Neoplasms

NCT07432178 2026-04-02

CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）

2,288 enrolled

Breast Neoplasms

NCT07506876 2026-04-02

Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

Phase 4 Not yet recruiting

Breast Cancer - Infiltrating Ductal Carcinoma

NCT07490509 2026-04-01

DOSABEMA

235 enrolled

Breast Neoplasms

NCT07495358 2026-04-01

KG-SMR-BC

Breast Neoplasms, Syndrome

NCT07502352 2026-03-31

Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)

192 enrolled

Breast Neoplasms

NCT07502820 2026-03-31

POWER

1,100 enrolled

Breast Neoplasms

NCT07502963 2026-03-31

PREDU

BreastGastrointestinalThoracic

70 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Motor Activity, Colorectal Neoplasms

NCT06828588 2026-03-30

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Phase EARLY_PHASE1 Not yet recruiting

BreastGastrointestinal

Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT07499089 2026-03-30

Together

24 enrolled